- Slice of Finance
- Posts
- Trinity Capital Appoints Josh Ruben as Managing Director of Life Sciences
Trinity Capital Appoints Josh Ruben as Managing Director of Life Sciences
Slice of Finance Team
26 Jul
Key Highlights:
Trinity Capital appoints Josh Ruben as Managing Director of Life Sciences.
Josh Ruben brings over 10 years of investment banking experience.
Ruben's track record includes $50 billion in transactions across M&A and capital raises.
Ruben joins from RBC Capital Markets, previously headed Life Science Tools and Diagnostics coverage.
Trinity Capital aims to grow its portfolio and invest in innovative life science companies.
Source (PR Newswire)
Notable Quotes:
"We are delighted to welcome Josh to our team. We believe his experience and his vast network of industry connections will prove to be invaluable as we continue to grow our portfolio and invest in innovative companies."
"I am thrilled to join the team at Trinity and eager to support groundbreaking companies within the life science sector. Trinity has a stellar reputation, and I look forward to leveraging my expertise to drive innovation and growth."
Our Take:
The appointment of Josh Ruben as Managing Director of Life Sciences at Trinity Capital Inc. is a strategic move that underscores the company's commitment to strengthening its foothold in the life sciences sector. Ruben's extensive background in investment banking, coupled with his significant transaction experience, positions him as a valuable asset to Trinity. His history of leading high-impact teams and his deep industry knowledge are likely to enhance Trinity's capacity to support and invest in groundbreaking life science companies. This addition is expected to drive both innovation and growth, further solidifying Trinity's reputation as a leading provider of diversified financial solutions to growth-oriented companies.